Page 5 - அலுவலகம் ஆஃப் மீடியா வாழ்க்கைத்தொழில்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from அலுவலகம் ஆஃப் மீடியா வாழ்க்கைத்தொழில்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In அலுவலகம் ஆஃப் மீடியா வாழ்க்கைத்தொழில்கள் Today - Breaking & Trending Today

Many local participants in Pfizer COVID-19 trial still double blinded


KINGSPORT — As the first rounds of the Pfizer COVID-19 vaccines are distributed to health care workers and nursing home residents, some local participants in the clinical trial are “anxiously waiting” to find out if they got the vaccine or a placebo.
Most participants don’t know for sure which of the two they received.
The vaccine has been given “emergency use authorization” but not yet FDA approval, so the participants are still part of an ongoing trial that is generating data for researchers.
Retired Eastman Chemical Co. chemist Bill Tindall said Monday that he and his wife, Judy, volunteered to participate in the Pfizer-BioNTech trial through Holston Medical Group after reading an Aug. 11 article in the Kingsport Times News that reported volunteers were needed. ....

United States , Judy Tindall , Bill Tindall , Phil Smith , Pat Shull , Mickey Shull , Holston Medical Group , Eastman Chemical Co , Office Of Media Affairs , Eastman Chemical , Kingsport Times News , Kingsport Mayor Pat Shull , Media Affairs , Times News , Vaccine Transition Option , Pfizer Media Relations , ஒன்றுபட்டது மாநிலங்களில் , ஜூடி டிண்டால் , ர சி து டிண்டால் , பில் ஸ்மித் , பேட் ஷூல்ல் , மிக்கி ஷூல்ல் , ஹோல்ஸ்டன் மருத்துவ குழு , ஈஸ்ட்மேன் இரசாயன இணை , அலுவலகம் ஆஃப் மீடியா வாழ்க்கைத்தொழில்கள் , ஈஸ்ட்மேன் இரசாயன ,

Vaccines and Related Biological Products Advisory Committee December 10, 2020 Meeting Announcement - 12/10/2020 - 12/10/2020


Agenda
The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older.
Meeting Materials
FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting, any background material will be made publicly available at the time of the advisory committee meeting, and additional materials will be posted on FDA s website after the meeting. ....

United States , Kathleen Hayes , Advisory Committee Information Line , Drug Administration , Advisory Committee , Products Advisory Committee , Office Of Media Affairs , Advisory Committee Meeting , Biologics Evaluation , Related Biological Products Advisory Committee , Emergency Use Authorization , Rulemaking Portal , Social Security , Dockets Management Staff , Related Biological Products , Public Docket , Dockets Management , Committee Information Line , Information Line , Media Affairs , Federal Register , Prabhakara Atreya , Federal Advisory Committee Act , Designated Federal Officer , Contact Information , Common Questions ,